Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-07 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-06 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |